Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 14 (2-3) , 353-360
- https://doi.org/10.1016/0169-5002(96)00559-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy, semantic and chemotherapy in advanced NSCLCAnnals of Oncology, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literatureLung Cancer, 1991
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Cancer statistics, 1991CA: A Cancer Journal for Clinicians, 1991
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Nonsurgical Combined Modality Therapies in Non-small Cell Lung CancerChest, 1986
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1983
- Reporting results of cancer treatmentCancer, 1981